Wendy Rachel Galpern is a Philadelphia, Pennsylvania based neurologist who is specialized in Neurology. Active license number of Wendy Rachel Galpern is MD456994 for Neurology in Pennsylvania. Her current practice location is 3400 Spruce Street, Philadelphia. Patients can reach her at 215-662-2219. Wendy Rachel Galpern is MD, PHD in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1013125285. Wendy Rachel Galpern specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Wendy Rachel Galpern speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1013125285
NPI Enumeration Date:
19 May, 2007
NPI Last Update On:
18 Nov, 2016
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Wendy Rachel Galpern are as mentioned below.
License Number
Specialization
State
Status
MD456994
Neurology
Pennsylvania
Primary
216351
Neurology
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Wendy Rachel Galpern 300 Bunn Dr Apt B205, Princeton, New Jersey
Zip:
08540-2876
Phone Number:
617-992-8068
Patients can reach Wendy Rachel Galpern at 3400 Spruce Street, Philadelphia, Pennsylvania or can call to book an appointment on 215-662-2219.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.